Evaluation of DOTA-chelated Neurotensin Analogs With Spacer-Enhanced Biological Performance for Neurotensin-Receptor-1-Positive Tumor Targeting

Nuclear Medicine and Biology- United States

doi 10.1016/j.nucmedbio.2015.07.010

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Imidazole-Derived Agonists for the Neurotensin 1 Receptor

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2014English

Differential Expression and Tumorigenic Function of Neurotensin Receptor 1 in Neuroendocrine Tumor Cells

Oncotarget
Oncology
2015English

Identification of Residues Involved in Neurotensin Binding and Modeling of the Agonist Binding Site in Neurotensin Receptor 1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Oncogenic Role of Neurotensin and Neurotensin Receptors in Various Cancers

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2017English

Neurotensin Receptor 1 Immunoreactivity in the Peripheral Ganglia and Carotid Body

European Journal of Histochemistry
MedicineCell BiologyHistologyBiophysics
2009English

Inhibition of Neurotensin Receptor 1 Selectively Sensitizes Prostate Cancer to Ionizing Radiation

Cancer Research
Cancer ResearchOncology
2011English

Structural Prerequisites for G-Protein Activation by the Neurotensin Receptor

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2015English

Heightened Amygdala Long-Term Potentiation in Neurotensin Receptor Type-1 Knockout Mice

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2008English

The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression

PLoS ONE
Multidisciplinary
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy